Safety pharmacology entails the assessment of the potential risks of novel pharmaceuticals for human use. As detailed in the ICH S7A guidelines, safety pharmacology for drug discovery involves a core battery of studies on three vital systems: central nervous (CNS), cardiovascular (CV), and respiratory.

Keywords: ICH S7A guidelines; cardiovascular system; central nervous system; respiratory system; risk assessment; safety pharmacology